Home » Medical Devices » Vascular Grafts Market

Vascular Grafts Market By Type (Endovascular Stent Grafts, Peripheral Vascular Grafts, Hemodialysis Access Grafts, Coronary Artery By-Pass Grafts), By Material (Synthetic, Biological, Biosynthetic), By Application (Cardiovascular Diseases, Aneurysm, Kidney Failure, Vascular Occlusion) – Growth, Share, Opportunities & Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 11337 | Report Format : PDF

Market Insights:

The purpose of this research study titled “Vascular Grafts Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global vascular grafts market. This report presents and analyses the major trends prevalent in the global vascular grafts market and the market’s size and forecast.

This report categorizes the global vascular grafts market in terms of type, material, application, and geographical distribution. Based on product type, the global vascular grafts market is categorized into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, and coronary artery bypass grafts. Synthetic (polytetrafluoroethylene (PTFE), polyurethane (P.U.), dacron, and others), biological (saphenous vein, bovine vein, and others), and biosynthetic are the various vascular graft materials studied in this report. In terms of application areas, vascular grafts find wide usage in the treatment of cardiovascular diseases, aneurysms, kidney failure, vascular occlusion, and diabetes. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global vascular grafts market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the vascular grafts market. The key players profiled in this report are Artegraft, Inc., B. Braun Melsungen AG, Cook Medical, Inc., C.R. Bard, Inc., CryoLife, Inc., Heart Medical Europe B.V., Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd.), LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. K.G., Medtronic plc, Shanghai Suokang Medical Implants Co. Ltd., Terumo Medical Corporation, Vascular Grafts Solutions Ltd., Vascular Grafts Ltd., Vascular Grafts Ltd.,

The global vascular grafts market is studied for the following material types:

  • Synthetic
  • Polytetrafluethylene (PTFE)
  • Polyurethane (P.U.)
  • Dacron
  • Others
  • Biological
  • Saphenous Vein
  • Bovine Vein
  • Others
  • Biosynthetic

Synthetic grafts are currently the most popular type all over the world. Polytetrafluoroethylene, polyurethane, dacron, etc., are highly preferred in the majority of grafting procedures. Easy availability, lesser cost, and higher tensile strength are some of the factors attributing to the larger market share of synthetic materials. However, biological materials have a higher demand in cardiovascular treatments and are expected to be the fastest-growing segment. Growing awareness about the benefits of biological grafts in terms of acceptance, biocompatibility, and technological advancement are the key factors contributing to the emergence of biological materials. At present, the internal thoracic artery and saphenous vein are the gold standard grafts used for cardiovascular procedures and outperform synthetic alternatives. However, the limited availability of these grafts challenges their widespread use. To address this challenge, tissue-engineered vascular grafts (TEVG) are being rigorously explored. Benefits of TEVG include the ability to remodel, grow, and repair in vivo without the need for autologous tissue transplant surgery.

The global vascular grafts market is studied for the following graft types:

  • Endovascular Stent Grafts
  • Peripheral vascular grafts
  • Hemodialysis Access Grafts
  • Coronary Artery By-pass Grafts

 In 2016, endovascular stent grafts occupied the largest share of the overall vascular graft market. Major factors influencing its dominance include the growing risk of chronic diseases such as renal conditions, cardiovascular diseases, and diabetes due to lifestyle changes, occupational factors, and dietary habits. Furthermore, the growing prevalence of hypertension and age-related chronic conditions has additionally urged the need for endovascular grafts and coronary artery bypass grafts in the market. Additionally, recent developments in vascular tissue engineering have resulted in the creation of cell-free grafts that are available on demand. However, restraints associated with cell-based grafts, such as cell expansion, long-term bioreactor culture, and cell sourcing, have motivated the introduction of completely cell-free vascular grafts.

The global vascular grafts market is studied for the following application areas:

  • Cardiovascular Diseases
  • Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Diabetes

In 2016, cardiovascular diseases accounted for over 20% of the global vascular grafts market on account of the growing prevalence of hypertension and other age-related cardiovascular diseases, with the highest prevalence of coronary artery diseases. Cardiovascular diseases are often associated with the blockage or narrowing of blood vessels and reduced blood flow. CVD mortality will surpass 23% by 2032, according to projections. Vascular surgery is often recommended for the treatment of CVDs when pharmaceutical administration and dietary and lifestyle modifications prove inadequate. Vascular grafts may be used to bypass or replace damaged vessels. At present, the most favored conduits for cardiovascular grafting are autologous arteries or veins, with the saphenous vein being the most common autograft option. Despite being the gold standard for grafting, saphenous vein grafting presents limited patency. Additionally, synthetic vascular grafts, though available as an alternative to autologous grafts, are used less due to poor patency rates.

Geographically, the global vascular grafts market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is the largest regional market for vascular grafts and will continue to dominate the global market. The high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and end-stage renal diseases and the corresponding growth in demand for surgical treatments largely contribute to the dominance of the North American market. The existence of a developed healthcare system, favorable reimbursements, and greater awareness about the treatment and management of chronic diseases are major features of the North American market. Additionally, Asia Pacific is anticipated to be the fastest-processing market for vascular grafts during the forecast period. The rapid evolution of healthcare systems, as well as the increasing penetration of major market players, contribute significantly to the movement of the Asia-Pacific market.

The detailed regional classification of the global vascular graft market is as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, U.K., France, and the Rest of Europe)
  • Asia Pacific (China, India, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (including the Gulf Cooperation Council and the rest of the Middle East and Africa)

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Vascular Grafts Market Portraiture
2.1.1. Global Vascular Grafts Market, by Type, 2016
2.1.2. Global Vascular Grafts Market, by Material, 2016
2.1.3. Global Vascular Grafts Market, by Application, 2016
2.1.4. Global Vascular Grafts Market, by Geography, 2016

Chapter 3. Vascular Grafts Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases (Coronary Artery Disease, Diabetes, ESRD, & Chronic Kidney Diseases)
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Vascular Grafts Market, by Type
4.3. Endovascular Stent Grafts
4.4. Peripheral Vascular Grafts
4.5. Hemodialysis Access Grafts
4.6. Coronary Artery By-pass Grafts

Chapter 5. Global Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Vascular Grafts Market, by Material
5.2. Synthetic
5.2.1. Polytetrafluethylene (PTFE)
5.2.2. Polyurethane (PU)
5.2.3. Dacron
5.2.4. Others
5.3. Biological
5.3.1. Saphenous Vein
5.3.2. Bovine Vein
5.3.3. Others
5.4. Biosynthetic

Chapter 6. Global Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Vascular Grafts Market, by Application
6.2. Cardiovascular Diseases
6.3. Aneurysm
6.4. Kidney Failure
6.5. Vascular Occlusion
6.6. Diabetes

Chapter 7. Global Vascular Grafts Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Vascular Grafts Market Analysis, 2015 – 2025
7.2.1. North America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.2.3. North America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.2.4. North America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Vascular Grafts Market Analysis, 2015 – 2025
7.3.1. Europe Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.3.3. Europe Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.3.4. Europe Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Vascular Grafts Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Vascular Grafts Market Analysis, 2015 – 2025
7.5.1. Latin America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Vascular Grafts Market Analysis, 2015 – 2025
7.6.1. MEA Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.6.3. MEA Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.6.4. MEA Vascular Grafts Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Artegraft, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. B. Braun Melsungen AG
8.3. Cook Medical, Inc.
8.4. C.R. Bard, Inc.
8.5. CryoLife, Inc.
8.6. Heart Medical Europe BV
8.7. Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd)
8.8. LeMaitre Vascular, Inc.
8.9. MAQUET Holding B.V. & Co. KG
8.10. Medtronic plc
8.11. Shanghai Suokang Medical Implants Co. Ltd.
8.12. Terumo Medical Corporation
8.13. Vascular Grafts Solutions Ltd.
8.14. Vascutek Ltd.
8.15. W. L. Gore & Associates, Inc.
8.16. Other Notable Players

List of Figures

FIG. 1 Vascular Grafts: Market Segmentation
FIG. 2 Global Vascular Grafts Market Share, by Type, 2016 (Value %)
FIG. 3 Global Vascular Grafts Market Share, by Material, 2016 Vs. 2025 (Value %)
FIG. 4 Global Vascular Grafts Market, by Application, 2016 (US$ Mn)
FIG. 5 Global Vascular Grafts Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Endovascular Stent Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Peripheral Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Hemodialysis Access Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Coronary Artery By-pass Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Polytetrafluethylene (PTFE) Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Polyurethane (PU) Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Dacron Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Synthetic Material Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Saphenous Vein Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global Bovine Vein Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Other Biological Materials Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 19 Global Biosynthetic Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Vascular Grafts for Cardiovascular Diseases Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Vascular Grafts for Aneurysm Market, 2015 – 2025 (US$ Mn)
FIG. 22 Global Vascular Grafts for Kidney Failure Market, 2015 – 2025 (US$ Mn)
FIG. 23 Global Vascular Grafts for Vascular Occlusion Market, 2015 – 2025 (US$ Mn)
FIG. 24 Global Vascular Grafts for Diabetes Market, 2015 – 2025 (US$ Mn)
FIG. 25 U.S. Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 26 Canada Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 27 U.K. Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 28 Germany Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 29 France Vascular Grafts Market, 2015-2025 (US$ Mn)
FIG. 30 Rest of Europe Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 31 Japan Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 32 China Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 33 India Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Asia Pacific Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 35 Brazil Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 36 Mexico Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 37 Rest of Latin America Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 38 GCC Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 39 Rest of Middle East and Africa Vascular Grafts Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 3 Global Synthetic Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 4 Global Biological Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 5 Global Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 Global Vascular Grafts Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 9 North America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 10 North America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Vascular Grafts Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 27 Artegraft, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 B. Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 C.R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Heart Medical Europe BV: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd): Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 LeMaitre Vascular, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 MAQUET Holding B.V. & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Medtronic plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Shanghai Suokang Medical Implants Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 Terumo Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 Vascular Grafts Solutions Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Vascutek Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 W. L. Gore & Associates, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

 Frequently Asked Questions:

What is the size of Vascular Grafts Market?

The market for Vascular Grafts is expected to reach US$ 3,636.9 Mn in 2025.

What is the Vascular Grafts Market CAGR?

The Vascular Grafts market is expected to see significant CAGR growth over the coming years, at 4.9%.

What is the Forecast period considered for Vascular Grafts Market?

The report is forecasted from 2017-2025.

What is the base year considered for Vascular Grafts Market?

The base year of this report is 2016.

Who are the major players in this market?

Arte graft, Inc., B. Braun Melsungen AG, Cook Medical, Inc., C.R. Bard, Inc.,CryoLife, Inc. are some of the major players in the global market.

Chromatography Consumables Market

Published:
Report ID: 40751

Europe Medical Device Contract Manufacturing Market

Published:
Report ID: 40558

Asia Pacific Medical Device Contract Manufacturing Market

Published:
Report ID: 40560

Cell Cytometry Market

Published:
Report ID: 40595

Medical Device Contract Manufacturing Market

Published:
Report ID: 40451

Particle Therapy Market

Published:
Report ID: 39662

Nebulizer Market

Published:
Report ID: 5926

India Medical Lasers Market

Published:
Report ID: 39267

Oncology Information System Market

Published:
Report ID: 39272

Neurostimulation Devices Market

Published:
Report ID: 14447

Manual Resuscitators Market

Published:
Report ID: 38693

Orthopedic Splints and Casts Market

Published:
Report ID: 18021

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN